4D Molecular Therapeutics, Inc. SEC filings FDMT
4D Molecular Therapeutics, Inc. has 439 filings in SEC EDGAR's recent list, going back to Aug 13, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 20, 2026 | Oct 16, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 144 | Notice of proposed sale | Oct 5, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 22, 2026 | Sep 16, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 14, 2026 |
| 144 | Notice of proposed sale | Sep 14, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 18, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 144 | Notice of proposed sale | Jul 10, 2026 | — |
| 144 | Notice of proposed sale | Jul 9, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 8-K |
Current report
Material agreement, New debt
|
Jun 29, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 23, 2026 |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| EFFECT | Filing | May 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| CORRESP | Letter to the SEC | May 11, 2026 | — |
| UPLOAD | Letter from the SEC | May 8, 2026 | — |
| S-3 | Shelf registration | May 7, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 7, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 24, 2026 | Mar 20, 2026 |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 3 | Initial insider ownership | Jan 7, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 7, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 20, 2025 |
| 3 | Initial insider ownership | Dec 19, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Other events
|
Nov 7, 2025 | Nov 6, 2025 |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 31, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 24, 2025 |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 4 | Insider transaction | Oct 20, 2025 | Oct 16, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 3 | Initial insider ownership | Oct 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 26, 2025 | Sep 23, 2025 |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 2, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| S-8 | Employee stock plan registration | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| EFFECT | Filing | Mar 24, 2025 | — |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| POS AM | Filing | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2025 | Feb 28, 2025 |
| POSASR | Filing | Feb 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 8, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Dec 11, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| 3 | Initial insider ownership | Nov 25, 2024 | Nov 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 13, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 4, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| 4 | Insider transaction | Sep 18, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 3 | Initial insider ownership | Aug 1, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2024 | Jul 23, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Other events
|
Jul 17, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 12, 2024 | Jul 10, 2024 |
| 144 | Notice of proposed sale | Jul 10, 2024 | — |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 144 | Notice of proposed sale | Jul 1, 2024 | — |
| 4 | Insider transaction | Jun 26, 2024 | Jun 24, 2024 |
| 144/A | Filing | Jun 25, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 7, 2024 | Jun 7, 2024 |
| 424B5 | Prospectus supplement | Jun 7, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | Apr 18, 2024 | Apr 16, 2024 |
| ARS | Annual report to shareholders | Apr 10, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 21, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 144 | Notice of proposed sale | Apr 1, 2024 | — |
| 4 | Insider transaction | Mar 29, 2024 | Mar 27, 2024 |
| 4 | Insider transaction | Mar 20, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FDMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1650648
- Former names
- 4D Molecular Therapeutics Inc. (until May 12, 2022); 4D Molecular Therapeutics Inc (until Sep 30, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.